These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2229131)

  • 1. Potentiation of cisplatin cytotoxicity by methylxanthines in vitro.
    Petru E; Boike G; Sevin BU
    J Cancer Res Clin Oncol; 1990; 116(5):431-3. PubMed ID: 2229131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.
    Boike GM; Petru E; Sevin BU; Averette HE; Chou TC; Penalver M; Donato D; Schiano M; Hilsenbeck SG; Perras J
    Gynecol Oncol; 1990 Sep; 38(3):315-22. PubMed ID: 2121626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence.
    Petru E; Sevin BU; Perras J; Boike G; Ramos R; Nguyen H; Averette HE
    Gynecol Oncol; 1990 Aug; 38(2):155-60. PubMed ID: 2387529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assay.
    Hightower RD; Sevin BU; Perras JP; Untch M; Angioli R; Ramos R; Averette H
    Gynecol Oncol; 1992 Nov; 47(2):186-90. PubMed ID: 1468696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay.
    Gerhardt RT; Perras JP; Sevin BU; Petru E; Ramos R; Guerra L; Averette HE
    Am J Obstet Gynecol; 1991 Aug; 165(2):245-55. PubMed ID: 1872324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Override of the radiation-induced mitotic block in human tumour cells by methylxanthines and its relationship to the potentiation of cytotoxicity.
    Musk SR; Steel GG
    Int J Radiat Biol; 1990 Jun; 57(6):1105-12. PubMed ID: 1971837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line.
    Schiano MA; Sevin BU; Perras J; Ramos R; Wolloch EH; Averette HE
    Gynecol Oncol; 1991 Oct; 43(1):37-45. PubMed ID: 1959786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor.
    Perez RP; Handel LM; Hamilton TC
    Gynecol Oncol; 1992 Jul; 46(1):82-7. PubMed ID: 1634144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro.
    Untch M; Sevin BU; Perras JP; Angioli R; Baibl A; Nguyen HN; Hightower RD; Averette HE
    Gynecol Oncol; 1992 Nov; 47(2):172-8. PubMed ID: 1468695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer.
    Sevin BU; Perras JP
    Am J Obstet Gynecol; 1997 Apr; 176(4):759-66; discussion 766-8. PubMed ID: 9125599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
    Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
    Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
    Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cisplatin activity by lonidamine in human ovarian cancer cells.
    Silvestrini R; Zaffaroni N; Villa R; Orlandi L; Costa A
    Int J Cancer; 1992 Nov; 52(5):813-7. PubMed ID: 1428236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
    Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.
    Xiao S; Zhang M; Liu C; Wang D
    Mol Genet Genomics; 2018 Oct; 293(5):1159-1167. PubMed ID: 29752546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.